Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bridge the Gap - SYNGAP Education is a non-profit patient advocacy and research foundation dedicated to SYNGAP1-related intellectual disability. The organization focuses on accelerating the development of treatments by funding international research, maintaining a global patient registry, and raising public awareness. They collaborate closely with academic institutions and biotechnology companies to advance therapeutic modalities such as gene therapy and antisense oligonucleotides. Additionally, the foundation provides critical educational resources and support networks for families and healthcare providers navigating the complexities of this rare genetic disorder. By facilitating natural history studies and identifying clinical endpoints, the foundation plays a pivotal role in preparing the SYNGAP1 community for upcoming clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bridge the Gap - SYNGAP Education.